Clinical Trial Update: To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

View source ↗

Summary

This clinical trial update assesses the safety and metabolic profile of lisdexamfetamine (Vyvanse) for treating attention-deficit/hyperactivity disorder in euth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Bipolar Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Attention Deficit/Hyperactivity Disorder, Bipolar Disorder | Status: COMPLETED